NovoCure Ownership | Who Owns NovoCure?


NovoCure Ownership Summary


NovoCure is owned by 81.75% institutional investors, 9.64% insiders, and 8.61% retail investors. Fmr is the largest institutional shareholder, holding 14.99% of NVCR shares. American Funds SMALLCAP World A is the top mutual fund, with 7.34% of its assets in NovoCure shares.

NVCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNovoCure81.75%9.64%8.61%
SectorHealthcare Stocks 56.95%9.28%33.77%
IndustryMedical Instruments & Supplies Stocks45.87%12.68%41.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.23M14.99%$483.66M
Blackrock funding, inc. /de13.03M12.03%$388.19M
Blackrock12.13M11.31%$207.83M
Vanguard group11.80M10.90%$351.52M
Capital investors8.87M8.20%$264.44M
Capital world investors4.82M4.45%$143.50M
State street3.01M2.80%$51.49M
Soleus capital management2.74M2.53%$81.64M
Geode capital management2.40M2.22%$71.54M
T. rowe price investment management1.69M1.56%$50.38M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp286.97K7.41%$8.55M
Invus financial advisors350.88K6.74%$6.01M
Soleus capital management2.74M5.13%$81.64M
Nordwand advisors312.15K3.83%$9.30M
Palo alto investors lp814.19K3.76%$24.26M
Taylor frigon capital management143.44K2.16%$4.27M
Granite investment partners686.73K0.88%$20.46M
Birchview capital, lp31.00K0.75%$923.80K
Essex investment management121.83K0.65%$3.63M
Emerald advisers547.56K0.63%$16.32M

Top Buyers

HolderShares% AssetsChange
Blackrock12.13M0.00%3.05M
Soleus capital management2.74M5.13%2.74M
Capital investors8.87M0.05%951.14K
Granite investment partners686.73K0.88%686.73K
Emerald advisers547.56K0.63%547.56K

Top Sellers

HolderShares% AssetsChange
Nordwand advisors312.15K3.83%-2.72M
T. rowe price investment management1.69M0.03%-1.12M
Morgan stanley806.52K0.00%-950.12K
Price t rowe associates inc /md/1.68M0.01%-638.38K
Marshall wace, llp270.95K0.01%-508.72K

New Positions

HolderShares% AssetsChangeValue
Granite investment partners686.73K0.88%686.73K$20.46M
Emerald advisers547.56K0.63%547.56K$16.32M
Silvercrest asset management group385.41K0.05%385.41K$6.60M
Emerald mutual fund advisers trust325.25K0.59%325.25K$9.69M
Adage capital partners gp200.00K0.01%200.00K$5.96M

Sold Out

HolderChange
Salem investment counselors-4.00
Mather group, llc.-15.00
Central trust-18.00
Raleigh capital management-26.00
Rise advisors-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20242495.51%88,494,339-4.72%811.11%11727.17%74-
Sep 30, 2024234-6.02%92,882,050-0.04%851.14%91-26.61%737.35%
Jun 30, 2024247-4.26%92,913,2194.09%861.23%123-1.60%676.35%
Mar 31, 20242587.05%89,258,298-1.39%831.17%125-2.34%6312.50%
Dec 31, 2023241-5.12%90,513,161-0.77%841.15%1285.79%56-11.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A7.94M7.34%1.42M
Fidelity Growth Compy Commingled Pl S7.65M7.07%74.37K
Fidelity Growth Compy Commingled Pl O7.46M6.89%-
Fidelity Growth Company Fund5.25M4.85%-38.51K
Vanguard Total Stock Mkt Idx Inv3.39M3.13%3.53K
American Funds Growth Fund of Amer A3.30M3.05%-
Capital Group Growth Fnd of Amer Comp3.30M3.05%-
BioPharma Credit Ord2.92M2.70%2.92M
iShares Russell 2000 ETF2.89M2.67%-21.95K
Vanguard Small Cap Index2.76M2.55%21.33K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 11, 2025Paravasthu Mukund Chief Operating OfficerSell$57.91K
Nov 02, 2024Paravasthu Mukund Chief Operating OfficerSell$734.18
Oct 31, 2024Puri Michal Nath Chief Human Resources OfficerSell$12.79K
Nov 01, 2024Leonard Frank X EVP, Pres., Novocure OncologySell$9.53K
Nov 01, 2024Paravasthu Mukund Chief Operating OfficerSell$2.54K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4-4
2024 Q3-1
2024 Q2-3
2024 Q1-6

NVCR Ownership FAQ


Who Owns NovoCure?

NovoCure shareholders are primarily institutional investors at 81.75%, followed by 9.64% insiders and 8.61% retail investors. The average institutional ownership in NovoCure's industry, Medical Instruments & Supplies Stocks, is 45.87%, which NovoCure exceeds.

Who owns the most shares of NovoCure?

NovoCure’s largest shareholders are Fmr (16.23M shares, 14.99%), Blackrock funding, inc. /de (13.03M shares, 12.03%), and Blackrock (12.13M shares, 11.31%). Together, they hold 38.34% of NovoCure’s total shares outstanding.

Does Blackrock own NovoCure?

Yes, BlackRock owns 11.31% of NovoCure, totaling 12.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 207.83M$. In the last quarter, BlackRock increased its holdings by 3.05M shares, a 33.55% change.

Who is NovoCure’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is NovoCure’s biggest shareholder by percentage of total assets invested, with 7.41% of its assets in 286.97K NovoCure shares, valued at 8.55M$.

Who is the top mutual fund holder of NovoCure shares?

American Funds SMALLCAP World A is the top mutual fund holder of NovoCure shares, with 7.34% of its total shares outstanding invested in 7.94M NovoCure shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools